Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot MRI study of rituximab plus methotrexate in rheumatoid arthritis
2007-001754-11Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of rituximab in rheumatoid arthritis (RA) (2 arms), sponsored by Roche. Primary endpoints: Synovial membrane enhancement, Bone marrow edema extent and 1 more. Started Jul 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-001754-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001754-11.